Dr. Melissa Ivers

DMD | Dentist



  
  1801 Camino De Salud Ne, Albuquerque
  New Mexico, 87102

  505-925-4031    Maps & Directions
Dr. Melissa Ivers is a Albuquerque, New Mexico based Dentist who is specialized in General Practice Dentistry. She may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Her current practice location is 1801 Camino De Salud Ne, Albuquerque. Patients can reach her at 505-925-4031.
Dr. Melissa Ivers is the primary dental care provider for patients of all ages. She is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Melissa Ivers speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Melissa Ivers
Specialization: Dentist
Gender:Female
Credentials: DMD
Accepts Medicare Assignment:May Accept
Practice Address:1801 Camino De Salud Ne, Albuquerque,
New Mexico, 87102
Phone:505-925-4031
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 1153554662
Enrollment ID: I20140508000771
NPI Number: 1740419100
NPI Enumeration Date: 07 Jul, 2009
NPI Last Update On: 24 May, 2024

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 7720 Calle Armonia Ne,
Albuquerque, New Mexico
Zip: 87113-2369
Phone Number: 303-319-1909
Patients can reach Dr. Melissa Ivers at 1801 Camino De Salud Ne, Albuquerque, New Mexico or can call to book an appointment on 505-925-4031. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.

Comments/ Reviews: